GLUT1 overexpression is a prognostic indicator for cancer. High levels of GLUT1 is associated with poor responsiveness to chemotherapy in AML. In the presence of several glucose transporters B-ALL cells rely specifically upon GLUT1 to maintain metabolism. This evidence concerns the gene SLC2A1 and acute myeloid leukemia.